Physician profile
Michael A Hiebert
NPI 1083154215
$2,691.55
in general payments reported to CMS, 2019-2025
20 companies · $350 in 2025
The $350 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $145 · 2022: $381 · 2023: $853 · 2024: $659 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,862.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $973.85 | 2022-2025 | Epclusa |
| Viiv Healthcare Company | $425.11 | 2019-2024 | Dovato, Cabenuva, Rukobia |
| Teleflex LLC | $148.62 | 2025 | Urolift |
| Lilly USA, LLC | $140.58 | 2019-2024 | Mounjaro |
| Allergan, INC. | $125.00 | 2020 | |
| Amarin Pharma, INC. | $124.99 | 2019 | |
| Abbvie INC. | $106.62 | 2022-2023 | |
| Insulet Corporation | $103.41 | 2024 | Omnipod |
| Janssen Products, LP | $99.00 | 2022 | |
| Janssen Biotech, INC. | $93.91 | 2022-2023 | Simponi Aria, Remicade, Simponi |
| Novo Nordisk INC | $68.87 | 2022-2023 | |
| Emd Serono, INC. | $62.51 | 2022-2023 | Serostim |
| Organogenesis INC. | $49.99 | 2023 | Puraply Antimicrobial |
| Merck Sharp & Dohme LLC | $47.29 | 2022-2023 | Delstrigo, Pifeltro, Dificid |
| Dexcom, INC. | $43.82 | 2023-2025 | Dexcom G6 Transmitter |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $18.61 | 2025 | Xyosted |
| Paratek Pharmaceuticals, INC. | $16.09 | 2023 | Nuzyra |
| Astellas Pharma US INC | $15.30 | 2023 | Veozah |
| Exact Sciences Corporation | $14.88 | 2023 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hiebert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.